Clinical trials
Approved for marketing Expanded access trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
112 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 1 |
| 2006 | 2 |
| 2009 | 1 |
| 2010 | 2 |
| 2012 | 1 |
| 2015 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Approved for marketing | 112 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 5 |
| Eli Lilly and Company | 5 |
| Genentech, Inc. | 5 |
| AstraZeneca | 3 |
| BioMarin Pharmaceutical | 3 |
| Gilead Sciences | 3 |
| Alexion Pharmaceuticals, Inc. | 2 |
| Amgen | 2 |
| Astellas Pharma Global Development, Inc. | 2 |
| Celgene | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cholestasis | 8 |
| Prostatic Neoplasms | 6 |
| Recurrence | 6 |
| Breast Neoplasms | 3 |
| HIV Infections | 3 |
| Lambert-Eaton Myasthenic Syndrome | 3 |
| Leukemia, Myeloid, Acute | 3 |
| Liver Diseases | 3 |
| Neoplasms | 3 |
| Aneurysm | 2 |
Trials
Showing 1 to 25 of 112. Each trial links to its page on Pharma Observatory.
12 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.